Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin versus crystalloid resuscitation in emergency department sepsis
ACTRN12624000327583Phase 4Recruiting
- Sponsor
- Royal Brisbane and Women's Hospital
- Start
- Jan 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of albumin (human) in sepsis (2 arms), sponsored by Royal Brisbane and Women's Hospital. Primary endpoint: Organ function. Started Jan 2024; status: recruiting.
02
Drugs
albumin (human)
03
Conditions
sepsis
Beyond the preview
Go deeper on ACTRN12624000327583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12624000327583.